Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Drug Injury Lawsuits: List of Some Cases Filed in First Half of 2021

August 9, 2021 By Law Offices of Thomas J. Lamb, P.A.

A drug injury lawsuit is a personal injury case or a wrongful death case involving a serious drug side effect or a severe adverse drug reaction. Here are some of the prescription medications for which drug injury lawsuits were filed against the responsible pharmaceutical company in the first half of 2021: Xeljanz Beovu Elmiron … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Actemra, Belviq, Beovu, Elmiron, Farxiga, Injectafer, Invokana, Jardiance, Ocaliva, Tasigna, Uloric

Uloric-Related Acute Kidney Injury And Acute Renal Failure Pointed Out In Safety Study

January 22, 2020 By Law Offices of Thomas J. Lamb, P.A.

According to a recent medical journal article, acute renal failure (ARF), or kidney failure, is reported as an adverse drug reaction 5.7 times more frequently with Uloric (febuxostat) than with other urate-lowering therapy (ULT) gout drugs, and 3.3 times more often with allopurinol. This is some important new Uloric drug safety information from our … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, acute renal failure, Kidney Failure, Renal Failure, Uloric

Uloric Increased Risk of Patient Cardiovascular Deaths, Says Health Canada

November 15, 2019 By Law Offices of Thomas J. Lamb, P.A.

Based on the results of the CARES study, Health Canada mandated an Uloric label change in early November 2019 which warns about an increased risk of Uloric-related cardiovascular deaths. Uloric is now only approved for use in Canada as a treatment “to lower serum uric acid levels in patients with gout who have an inadequate response or intolerance … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Cardiovascular death, Uloric

Uloric Warning: Avoid Uloric If Prior Myocardial Infarction, Stroke, Or Unstable Angina

August 5, 2019 By Law Offices of Thomas J. Lamb, P.A.

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) issued a Uloric warning in July 2019 stating that patients with prior myocardial infarction, stroke, or unstable angina should avoid Uloric as there is a higher risk of death. From this July 2019 MHRA Drug Safety Update, “Febuxostat (Adenuric): increased risk of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Cardiovascular death, Myocardial Infarctions (MI), Strokes, Uloric

Uloric Lawsuits Follow Recent FDA Warnings About Heart-Related Deaths And Side Effects

May 1, 2019 By Law Offices of Thomas J. Lamb, P.A.

Following recent FDA-mandated label changes, there have been Uloric lawsuits filed against Takeda Pharmaceuticals America, Inc., the manufacturer of Uloric. Uloric (febuxostat) tablets have been generally prescribed for the management of chronic gout since 2009. In February 2019 the FDA required its strongest safety warning, i.e., Bolded … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Cardiovascular death, Heart Attacks, Strokes, Uloric

February 2019: Uloric “Black-Box Warning” For Heart-Related Deaths, Cardiovascular Side Effects

March 5, 2019 By Law Offices of Thomas J. Lamb, P.A.

The FDA has required its strongest safety warning, i.e., Bolded Warning or Black-Box Warning, be included on a new Uloric drug label to inform about the increased risk of heart-related death and death from all causes with Uloric. From this February 2019 FDA Drug Safety Communication, "FDA adds Boxed Warning for increased risk of death with gout … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cardiovascular events, Heart Attacks, heart-related deaths, Myocardial Infarctions (MI), nonfatal myocardial infarctions, Strokes, Uloric

Uloric Recall Discussed By FDA Advisory Committees In January 2019

January 25, 2019 By Law Offices of Thomas J. Lamb, P.A.

On January 10, 2019 the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee panelists discussed the potential biological mechanisms behind cardiovascular (CV) events associated with Uloric (febuxostat) use. From this January 11, 2019 MedPage Today report, “Make Uloric Second-Line for Gout, FDA Advisors Say”, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Cardiovascular death, cardiovascular events, Uloric

Will FDA Order Uloric Recall Requested In June 2018 By Public Citizen

July 13, 2018 By Law Offices of Thomas J. Lamb, P.A.

The consumer advocacy group Public Citizen asserts that a FDA Uloric recall is necessary following results of a large postmarketing study that showed higher rates of fatal cardiovascular (CV) events and all-cause mortality in patients taking the drug. More exactly, it is the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout … [Read more...]

Filed Under: Unsafe Drugs Tagged With: card, Cardiovascular death, drug side effects, FDA, Uloric

November 2017 FDA Alert: Uloric May Increase Heart-Related Deaths Risk

November 17, 2017 By Law Offices of Thomas J. Lamb, P.A.

On November 15, 2017 there was an email sent by the FDA about this MedWatch Safety Alert, “Febuxostat (Brand Name Uloric): Drug Safety Communication – FDA to Evaluate Increased Risk of Heart-related Death”, from which we get this excerpt: ISSUE: FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Cerebral Vascular Accident (CVA), Cerebrovascular Accidents, Heart Attacks, heart-related deaths, Strokes, Uloric

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.